Trials / Completed
CompletedNCT01599572
Effect of Zinc Supplementation on Serum Zinc Level in Nursing Home Elderly
Zinc Intervention in Nursing Home Elderly
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Tufts University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
Background: Zinc supplementation has the potential to improve serum zinc levels and immunity of zinc deficient nursing home elderly. Objective: To determine the effect of zinc supplementation of 30mg/d for 3 months on serum zinc levels and T-cell mediated function of zinc deficient nursing home elderly. Design: This is a randomized, double-blind, placebo-controlled study. Outcome measures included change in serum zinc levels and various T-cell mediated immune factors between baseline and month 3. Hypotheses: The investigators hypothesize that zinc supplementation of 30mg/d for 3 months will improve serum zinc levels as well as various T-cell mediated immune factors in zinc deficient nursing home elderly.
Detailed description
Four hundred and forty-two medical charts were screened from three participating nursing homes; 53 nursing home elderly were eligible and therefore were screened for low serum zinc levels (\<70µg/dL). Of these, 31 (58%) had low serum zinc levels. Participants were randomized into either the placebo (N=16) or the zinc supplemented (N=15) group. Six participants did not complete the study for various reasons including refusal to take study capsules, and advice from their physicians; one participant in the zinc group experienced nausea on two consecutive days following ingestion of the zinc capsule at the beginning of the study. A total of 25 participants completed the study with 13 and 12 receiving the placebo and zinc capsules, respectively, over a period of three months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | zinc supplementation | 30mg/day of zinc in the form of zinc gluconate |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2012-05-16
- Last updated
- 2015-05-21
Source: ClinicalTrials.gov record NCT01599572. Inclusion in this directory is not an endorsement.